Skip to content

AVIR - Atea Pharmaceuticals, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Atea Pharmaceuticals Inc

AVIR · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

AVIRAtea Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $6.45
52-wk low: $2.78
Prev close: $4.49
Mkt cap: $448.3M
Beta: 0.27
P/S: 1.6x

Smart money

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$123.7M

TS
Two Sigma
Q2 2026 13F
$7.0M
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 26.8% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $448M

Valuation

P/S1.55
P/B2.07

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: AVIR
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $448.34M
Beta: 0.27

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.1x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-58.1%

$5.3M

position

DS

D.E. Shaw

Q2 2026 13F

$1.6M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for AVIR

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.41+26.8%

-$0.56 expected

Next report

What the street expects next

EPS expected

-$0.51

-$0.59 to -$0.42

Revenue expected

$0.00

1 analysts

Last 30 days

1up0down

Analysts raising estimates

Estimate drift

+0.04

Change in 30 days

-58.1%

ROA-36.7%

Growth

Beta0.27